Applied Materials (AMAT) is experiencing a turbulent period, despite promising growth forecasts for fiscal 2025. The biotech company's stock performance showed fluctuations, with instances of both minor declines and increases. Market analyses compare them against competitors like ASML in reference to AI stock superiority, while debates persist on whether the stock is undervalued by 28%. CCM Investment Advisers and Ridgewood Investments LLC expanded their positions in the company, while International Assets Investment Management trimmed theirs. The Law Offices of Frank R. Cruz is ongoing with an investigation on behalf of AMAT investors. AMAT's quarterly performance and sales were better-than-expected, although revenue guidance slightly missed expectations. Notably, institutional owners hold 82% of the company. Concerns arise about AMAT's reliance on international sales and recent slide due to general pullback from investors. Despite this, Hedgeye calls AMAT a short idea, forecasting significant downside amidst growth concerns. AMAT recently announced plans to expand the global EPIC platform and released full-year results, drawing analyst estimates revisions.
Applied Materials AMAT News Analytics from Thu, 15 Aug 2024 07:00:00 GMT to Sat, 11 Jan 2025 08:45:19 GMT -
Rating 1
- Innovation 7
- Information 5
- Rumor -3
